Members |
targetComponentId |
Pupil constriction |
Constricted pupil |
Pupil dilation |
Dilated pupil |
membrana pupillaris i vänster öga |
Pupillary membrane |
membrana pupillaris i höger öga |
Pupillary membrane |
Pur-In-Mix insulin adverse reaction |
Insulin adverse reaction |
Pur-In-Mix insulin allergy |
Allergy to insulin |
Purified protein derivative |
Product containing tuberculin purified protein derivative (medicinal product) |
Purified protein derivative |
Product containing tuberculin purified protein derivative (medicinal product) |
Purpose of radiotherapy |
Radiation oncology AND/OR radiotherapy |
syfte med strålbehandling |
Radiation oncology AND/OR radiotherapy |
Pustular |
Pustule |
Putrescine |
Putrescine |
Pyemotes tritici |
Pyemotes ventricosus (organism) |
antiinflammatoriskt medel med pyrazolderivat |
Pyrazole derivative |
pyridostigminbromid 60 mg/5 ml, sirap |
Product containing precisely pyridostigmine bromide 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
pyridoxinberoendesyndrom |
Pyridoxine-dependent epilepsy (disorder) |
pyridoxinpreparatallergi |
Allergy to pyridoxine (finding) |
Pyrophosphotransferase |
Pyrophosphotransferase |
Pyrrhura hypoxantha |
Pyrrhura molinae subspecies molinae (organism) |
Pyrroline-5-carboxylate reductase deficiency |
Deficiency of pyrroline-5-carboxylate reductase |
Q-T interval |
QT interval feature |
Quadricoccus australiensis |
Quatrionicoccus australiensis (organism) |
kinaprilallergi |
Non-allergic hypersensitivity to quinapril (finding) |
Quinapril hydrochloride |
Product containing quinapril (medicinal product) |
Quinidine gluconate 324mg |
Product containing only quinidine in oral dose form (medicinal product form) |
kinidinglukonat 324 mg , tablett med modifierad frisättning |
Product containing only quinidine in oral dose form (medicinal product form) |
kinidinglukonat 324 mg, depåtablett |
Product containing only quinidine in oral dose form (medicinal product form) |
kinidinsulfat 300 mg, tablett med modifierad frisättning |
Product containing only quinidine in oral dose form (medicinal product form) |
kinidinsulfat 300 mg, depåtablett |
Product containing only quinidine in oral dose form (medicinal product form) |
kinindihydroklorid 300 mg/ml, infusionsvätska, lösning, ampull 1 ml |
Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for injection (clinical drug) |
kininhydroklorid 300 mg/ml, infusionsvätska, lösning, ampull 2 ml |
Quinine 300 mg/mL solution for injection |
R1 phenotype |
CDe haplotype (finding) |
R2 phenotype |
cDE haplotype (finding) |
RBC color/staining NOS |
Red blood cell colour |
RBC colour/staining NOS |
Red blood cell colour |
RETIRED Concepts |
Inactive value (foundation metadata concept) |
antihumant T-lymfocytglobulin från kanin 25 mg, pulver och vätska till injektionslösning, flaska |
Rabbit anti-human T-lymphocyte globulin 25 mg powder for solution for injection vial |
Racemase |
Racemase |
Radiation therapy |
Radiation oncology AND/OR radiotherapy |
Radical neurolysis |
Destruction - action |
Radiculitis |
Radiculitis |
Radionuclide dacryocystography |
Radionuclide lacrimal flow study |
planering av strålbehandling med magnetresonanstomografi |
Magnetic resonance imaging for radiotherapy planning |
Radiotherapy purpose - NOS |
Radiation oncology AND/OR radiotherapy |
Radiotherapy purpose - NOS |
Radiation oncology AND/OR radiotherapy |
Railroading |
Action |
Ralstonia |
Ralstonia |
Ralstonia eutropha |
Wautersia eutropha (organism) |
Ramadiers operation |
Drainage of petrous apex of mastoid |
pericementitis fibrosa-syndrom med förgrening |
Periodontal disease |
ramiprilallergi |
Non-allergic hypersensitivity to ramipril |
ramucirumab 10 mg/ml, injektionsvätska, lösning |
Product containing only ramucirumab (medicinal product) |
ramucirumab10 mg/ml, vätska för intravenös infusion, lösning |
Product containing only ramucirumab (medicinal product) |
Rancho-skalan - nivåer för kognitiv funktion |
Rancho Los Amigos Levels of Cognitive Functioning Scale (assessment scale) |
Range of motion exercise |
Range of motion exercise |
ranibizumab 10 mg/ml, vätska för intravitreal injektion, flaska 0,05 ml |
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
syndrom efter våldtäktstrauma |
Post-trauma response |
syndrom efter våldtäktstrauma: sammansatt reaktion |
Post-trauma response |
syndrom efter våldtäktstrauma: tyst reaktion |
Post-trauma response |
snabbt progredierande parodontit |
Aggressive periodontitis |
rasburikas 7,5 mg, pulver för beredning av infusionsvätska |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
rasburikas 7,5 mg, pulver och vätska till infusionsvätska |
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
reaktiva cellulära förändringar i samband med intrauterint preventivmedel |
Reactive cellular changes caused by intrauterine contraceptive device (finding) |
potential för förbättrad stresshantering i samhälle |
Ready for enhanced community coping |
Reason not stated concept |
Outdated component (foundation metadata concept) |
Reattachment of retina by photocoagulation |
Repair of retina for retinal detachment by photocoagulation |
Recent |
Recent |
Recessive congenital ichthyosiform erythroderma |
Trichothiodystrophy (disorder) |
Recomb human follicle stim horm alpha 1200iu inj pdr+diluent |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
rekombinant humant follikelstimulerande hormon 1 200 IE, pulver och vätska till injektionslösning |
Pituitary follicle stimulating hormone 1200 unit powder for solution for injection vial |
rekombinant alfaglukosidas 50 mg, pulver till injektionsvätska, flaska |
Product containing only alpha-glucosidase (medicinal product) |
rekombinant antihemofilifaktorpreparat, 1 000 IE, injektionsvätska, lösning, flaska 1 ml |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 1 000 IE pulver till injektionsvätska, flaska |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 1 500 IE, injektionsvätska, lösning, flaska 1 ml |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 1 500 IE, pulver till injektionsvätska, flaska |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 2 000 IE, injektionsvätska, lösning, flaska 1 ml |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 2 000 IE, pulver till injektionsvätska, flaska |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 250 IE, injektionsvätska, lösning, flaska 1 ml |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 250 IE, pulver till injektionsvätska, flaska |
Octocog alfa 250 international unit powder for solution for injection vial |
rekombinant antihemofilifaktorpreparat, 3 000 IE, injektionsvätska, lösning, flaska |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 500 IE, injektionsvätska, lösning, flaska 1 ml |
Antihemophilic factor agent only product |
rekombinant antihemofilifaktorpreparat, 500 IE, pulver till injektionsvätska, flaska |
Product containing precisely octocog alfa 500 international unit/1 vial powder for conventional release solution for injection (clinical drug) |
rekombinant koagulationsfaktor IX , 1 000 IE, pulver och vätska till injektionslösning, flaska |
Product containing only nonacog alfa (medicinal product) |
rekombinant koagulationsfaktor IX 1 000 IE, pulver till injektionsvätska, lösning, flaska |
Product containing only nonacog alfa (medicinal product) |
rekombinant koagulationsfaktor IX, 1 000 IE, pulver till injektionsvätska, flaska |
Nonacog alfa 1000 international unit powder for solution for injection vial |
rekombinant koagulationsfaktor IX , 250 IE, pulver och vätska till injektionslösning, flaska |
Product containing only nonacog alfa (medicinal product) |
rekombinant koagulationsfaktor IX 250 IE, pulver till injektionsvätska, lösning, flaska |
Product containing only nonacog alfa (medicinal product) |
rekombinant koagulationsfaktor IX, 250 IE, pulver till injektionsvätska, flaska |
Nonacog alfa 250 international unit powder for solution for injection vial |
rekombinant koagulationsfaktor IX , 500 IE, pulver och vätska till injektionslösning, flaska |
Product containing only nonacog alfa (medicinal product) |
rekombinant koagulationsfaktor IX 500 IE, pulver till injektionsvätska, lösning, flaska |
Product containing only nonacog alfa (medicinal product) |
rekombinant koagulationsfaktor IX , 500 IE, pulver till injektionsvätska, flaska |
Nonacog alfa 500 international unit powder for solution for injection vial |
rekombinant koagulationsfaktor VIIa , 120 000 IE, pulver och vätska till injektionslösning, flaska |
Coagulation factor VIIa only product in parenteral dose form |
rekombinant koagulationsfaktor VIIa 120 000 IE, pulver till injektionsvätska, lösning, flaska |
Coagulation factor VIIa only product in parenteral dose form |
rekombinant koagulationsfaktor VIIa , 240 000 IE, pulver och vätska till injektionslösning, flaska |
Coagulation factor VIIa only product in parenteral dose form |
rekombinant koagulationsfaktor VIIa 240 000 IE, pulver till injektionsvätska, lösning, flaska |
Coagulation factor VIIa only product in parenteral dose form |
rekombinant koagulationsfaktor VIIa , 60 000 IE, pulver och vätska till injektionslösning, flaska |
Coagulation factor VIIa only product in parenteral dose form |
rekombinant koagulationsfaktor VIIa 60 000 IE, pulver till injektionsvätska, flaska |
Coagulation factor VIIa only product in parenteral dose form |
rekombinant humant follikelstimulerande hormon alfa 150 IE/lutropin alfa 75 IE, pulver och vätska till injektionslösning, flaska |
Product containing only follitropin alfa and lutropin alfa (medicinal product) |
rekombinant humant follikelstimulerande hormon alfa 1 050 IE, pulver för beredning av injektionsvätska |
Product containing only follitropin alfa (medicinal product) |
rekombinant humant follikelstimulerande hormon alfa 1 050 IE, pulver för beredning av injektionsvätska + spädningsvätska |
Product containing only follitropin alfa (medicinal product) |
rekombinant humant follikelstimulerande hormon alfa 150 IE, pulver och vätska till injektionslösning, ampull |
Follitropin alfa 300 unit/mL solution for injection |